High SVR12 Rates in HCV Genotype 1b-Infected Patients Receiving ABT-450/r/Ombitasvir and Dasabuvir with or without Ribavirin Regardless of Baseline Characteristics
54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington D.C., United States Of America, 5 - 09 September 2014, vol.1, no.1, pp.103
- Publication Type: Conference Paper / Full Text
- Volume: 1
- City: Washington D.C.
- Country: United States Of America
- Page Numbers: pp.103
- Istanbul University Affiliated: No